On Monday, Kosmos Energy Ltd (NYSE:KOS)’s shares declined -3.02% to $8.34, as Kosmos Energy, declared the following plan for its first quarter 2015 results:
Earnings Release: Monday, May 4, 2015, pre-market via Business Wire and the Corporation’s website at www.kosmosenergy.com.
Kosmos Energy Ltd. explores for and produces oil and gas in Africa, Europe, and South America. Its asset portfolio includes production and other development projects in offshore Ghana, as well as exploration licenses with hydrocarbon potential in offshore Ireland, Mauritania, Morocco, Senegal, and Suriname.
Orexigen Therapeutics, Inc. (NASDAQ:OREX)’s shares dropped -1.23% to $8.00, during the last trading session on Monday, as Orexigen® Therapeutics, declared that administration will present a corporate overview at the 2015 Needham Healthcare Conference in New York. The presentation is planned for Tuesday, April 14th at 12:50 p.m. Eastern Time.
Orexigen Therapeutics, Inc., a biopharmaceutical corporation, focuses on the development of pharmaceutical products in the United States. The corporation offers Contrave for the treatment of obesity. I
At the end of Monday’s trade, Biocept Inc (NASDAQ:BIOC)‘s shares dipped -2.09% to $2.34, as Biocept, declared that it has reached a clinical partnership with University of California, San Diego Moores Cancer Center to determine the clinical utility of detecting biomarkers present in CTCs and ctDNA in blood samples for non-small cell lung cancer patients using Biocept’s OncoCEE(TM) LU platform and CEE-Selector(TM) technology.
Biocept offers a highly sensitive and quantitative blood-based method for the detection and monitoring of cancer mutations, which can assist inform treatment decisions based on genomic information. The Corporation is engaged in clinical study collaborations designed to demonstrate the utility of its liquid biopsy diagnostics to detect biomarker status in cancer patients, and for the assessment of tumor treatment response over time.
Biocept, Inc., a cancer diagnostics corporation, develops and commercializes proprietary circulating tumor cell (CTC) and circulating tumor DNA tests utilizing a standard blood sample.
Staples, Inc. (NASDAQ:SPLS), ended its Monday’s trading session with -2.93% loss, and closed at $16.23, as Staples, is making a commitment to education in Ecuador by donating $10,000 to assist fund a school through international charity and partner, Free The Children. Staples is also sending five teachers, selected as winners in the Staples Me to We Teacher Appreciation Contest, to Ecuador where they will assist build the Staples-funded school.
Staples, Inc., together with its auxiliaries, operates office products superstores. It operates through three segments: North American Stores & Online, North American Commercial, and International Operations.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
